Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation

Nexium Capsules Specific Clinical Experience Investigation Concerning Helicobacter Pylori Eradication

The purpose of this study is to confirm the safety profile / factors which impact safety and efficacy in patients given triple therapy for Helicobacter pylori eradication with Nexium + amoxicillin (AMPC) + clarithromycin (CAM), or Nexium + AMPC + metronidazole (MNZ) in usual post-marketing use.

Nexium capsules Specific Clinical Experience Investigation concerning Helicobacter pylori eradication

Inclusion criteria:

• Triple therapy for H.pylori eradication to stomach started after endoscopic treatment for gastric ulcer
• Triple therapy for H.pylori eradication to stomach started after endoscopic treatment for duodenal ulcer
• Triple therapy for H.pylori eradication to stomach started after endoscopic treatment for gastric MALT lymphoma
• Triple therapy for H.pylori eradication to stomach started after endoscopic treatment for idiopathic thrombocytopenic purpura
• Triple therapy for H.pylori eradication to stomach started after endoscopic treatment for early gastric cancer

Exclusion Criteria:

- H.pylori negative at the time when the triple therapy is started